Results 1 to 10 of about 1,315,331 (224)

Left atrial thrombus after placement of watchman device [PDF]

Clinical Case Reports, 2022
Atrial fibrillation is an irregular rhythm with increased risk of morbidityand mortality. Commonly due to thromboembolism at the left atrialappendage.
Emmanuel Isang, Shawna Stephens, Tyler Coombes, Lon Abney, Gayathri Baljepally   +4 more
doaj   +3 more sources

Surgical Removal of a Migrated WATCHMAN Device [PDF]

Methodist DeBakey Cardiovascular Journal
The WATCHMAN™ atrial appendage closure device is designed to reduce the risk of stroke in patients with nonvalvular atrial fibrillation who are not suitable candidates for long-term oral anticoagulation therapy.
Andrew G. Saleeb, Juan M. Farina, Asher Jenkins, Rawan Zeineddine, Kenan Shawwaf, Eric H. Yang, Said Alsidawi, Dawn E. Jaroszewski, Francis X. Downey   +8 more
doaj   +3 more sources

A Case of Idiopathic Chest Pain Following Watchman Device Placement [PDF]

Clinical Case Reports
Chest pain following left atrial appendage closure (LAAC) with the Watchman device is rare but can occur due to complications such as pericarditis or myocardial infarction.
Salman Pervaiz, Abeera Azam, Masab Ali, Muhammad Husnain Ahmad, Preetham Muskula, Tyrone Galbreath, Muhammad Hassan   +6 more
doaj   +3 more sources

Failure of Complete Endothelialization of a Watchman Device 3 Years Post-Implantation [PDF]

JACC: Case Reports, 2021
We report an unusual case of incomplete endothelialization of the Watchman device >3 years after its implantation. Animal data suggest that device endothelialization occurs ∼45 days post-implantation; however, data on humans are lacking.
Uyanga Batnyam, MD, Alexandra Tuluca, MD, Christian F. Witzke, MD, Allan M. Greenspan, MD, Sumeet K. Mainigi, MD   +4 more
doaj   +4 more sources

Reoccurrence of Stroke in a Patient With Peri-Device Leak of WATCHMAN Device [PDF]

Journal of Investigative Medicine High Impact Case Reports, 2020
Atrial fibrillation is the leading cause of cardioembolic stroke, with emboli most commonly originating from the left atrial appendage. We report the case of a 71-year-old male with left atrial appendage closure via implantation of the WATCHMAN device ...
Jordan Perkins MPH, Riwaj Bhagat MD, Matthew Nichols BS, Jignesh Shah MD   +3 more
doaj   +3 more sources

Less Is More: Management of Left Atrial Appendage Perforation With Impending Cardiac Tamponade Following Watchman Device Placement [PDF]

Case Reports in Cardiology
By 2030, the United States will have over 12 million people with atrial fibrillation, which carries a five-fold increase in risk of stroke. Watchman device is an alternative in patients who are poor candidates for anticoagulation. Here, we present a rare
Syeda Beenish Bareeqa, Ahmad Nawa, Arooge Towheed, Juwairiya Shuroog, Karthik Ramireddy, Shahabuddin Soherwardi   +5 more
doaj   +2 more sources

A novel method using body surface steel ball as a reference scale to measure the left atrial appendage for optimal selection of Watchman device [PDF]

Frontiers in Cardiovascular Medicine
BackgroundLeft atrial appendage closure (LAAC) is an alternative to oral anticoagulation for stroke prevention in non-valvular atrial fibrillation (AF). Selecting the appropriate size of Watchman device is very important intra-procedure.
He Jin, Mingjun Feng, Xianfeng Du, Binhao Wang, Yibo Yu, Guohua Fu, Caijie Shen, Huimin Chu   +7 more
doaj   +2 more sources

Percutaneous left atrial appendage closure with the Watchman device: a systematic review [PDF]

Advances in Interventional Cardiology
Atrial fibrillation (AF) is the most commonly observed arrhythmia in the world and its prevalence increases with age. The main and most severe complication of AF is ischemic stroke.
Jakub Maksym, Marcin Grabowski, Tomasz Mazurek   +2 more
doaj   +2 more sources

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device [PDF]

JACC: Case Reports, 2020
A 75-year-old woman with recent left atrial appendage closure with the Watchman device (Boston Scientific, Natick, Massachusetts) presented with recurrent left pleural effusion. The constellation of chest pain, pericardial effusion, and exudative pleural
Rim Halaby, MD, Lohit Garg, MD, Alejandro De Feria, MD, Francis E. Marchlinski, MD, Pasquale Santangeli, MD, PhD   +4 more
doaj   +2 more sources

Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure) [PDF]

BMC Cardiovascular Disorders, 2022
Background Various randomized multicenter studies have shown that percutaneous left atrial appendage closure (LAAC) is not inferior in stroke prevention compared to vitamin K antagonists (VKA) and can be performed safely and effectively.
Lucie Kretzler, Christoph Mues, Carsten Wunderlich, Anke Langbein, S. G. Spitzer, Ulrich Gerk, Sebastian Schellong, Thomas Ketteler, Hans Neuser, Marcus Schwefer, Ruth Strasser, Karim Ibrahim, Steffen Schoen, Marian Christoph   +13 more
doaj   +2 more sources